Brief: Cleveland BioLabs announces a $1.1 mln cost realignment with Department of Defense

Statera Biopharma

11/10/2016 13:46

Oct 11 (Reuters) - Cleveland Biolabs Inc  CBLI.O  
    * Announces a $1.1 million cost realignment with Department 
of Defense 
    * Says modified its joint warfighter medical research 
program contract award number w81xwh-15-c-0101 with CBLI valued 
at up to $9.2 million 
 
Source text for Eikon:  ID:nMKWwNSfCa  
Further company coverage:  CBLI.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))